Li, L.; Rojiani, A. M.; Siemann, D. W. Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi’s Sarcoma. AO 2002, 41, 91-97.